Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07382401Not ApplicableNot Yet Recruiting

Developing Immersive Gamification Technology Systems For The Rehabilitation Management Of Adults With Parkinson's Disease (Phase 1 Trial)

Role: lead

NCT06100341Not ApplicableUnknown

ImGTS for Patients With Cerebral Palsy and With Mobility Limitations (Phase 2)

Role: lead

NCT06072014Not ApplicableUnknown

ImGTS for Patients With Behavioral and Psychological Symptoms of Dementia (Phase 2)

Role: lead

NCT05265182Not ApplicableCompleted

ImGTS for Patients With Behavioral and Psychological Symptoms of Dementia

Role: lead

NCT05299905Not ApplicableCompleted

ImGTS for Patients With Cerebral Palsy and With Mobility Limitations

Role: lead

All 5 trials loaded